Literature DB >> 26345662

Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases.

C C Thinnes1, A Tumber, C Yapp, G Scozzafava, T Yeh, M C Chan, T A Tran, K Hsu, H Tarhonskaya, L J Walport, S E Wilkins, E D Martinez, S Müller, C W Pugh, P J Ratcliffe, P E Brennan, A Kawamura, C J Schofield.   

Abstract

There is interest in developing potent, selective, and cell-permeable inhibitors of human ferrous iron and 2-oxoglutarate (2OG) oxygenases for use in functional and target validation studies. The 3-component Betti reaction enables efficient one-step C-7 functionalisation of modified 8-hydroxyquinolines (8HQs) to produce cell-active inhibitors of KDM4 histone demethylases and other 2OG oxygenases; the work exemplifies how a template-based metallo-enzyme inhibitor approach can be used to give biologically active compounds.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26345662     DOI: 10.1039/c5cc06095h

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  9 in total

Review 1.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

2.  Functionalized Spiroindolines with Anticancer Activity through a Metal-Free Post-Ugi Diastereoselective One-Pot Cascade Reaction.

Authors:  Zhi-Gang Xu; Shi-Qiang Li; Jiang-Ping Meng; Dian-Yong Tang; Liu-Jun He; Jie Lei; Hui-Kuan Lin; Hong-Yu Li; Zhong-Zhu Chen
Journal:  Chemistry       Date:  2018-04-20       Impact factor: 5.236

3.  Assessing histone demethylase inhibitors in cells: lessons learned.

Authors:  Stephanie B Hatch; Clarence Yapp; Raquel C Montenegro; Pavel Savitsky; Vicki Gamble; Anthony Tumber; Gian Filippo Ruda; Vassilios Bavetsias; Oleg Fedorov; Butrus Atrash; Florence Raynaud; Rachel Lanigan; LeAnne Carmichael; Kathy Tomlin; Rosemary Burke; Susan M Westaway; Jack A Brown; Rab K Prinjha; Elisabeth D Martinez; Udo Oppermann; Christopher J Schofield; Chas Bountra; Akane Kawamura; Julian Blagg; Paul E Brennan; Olivia Rossanese; Susanne Müller
Journal:  Epigenetics Chromatin       Date:  2017-03-01       Impact factor: 4.954

4.  Small molecule KDM4s inhibitors as anti-cancer agents.

Authors:  Hongzhi Lin; Qihang Li; Qi Li; Jie Zhu; Kai Gu; Xueyang Jiang; Qianqian Hu; Feng Feng; Wei Qu; Yao Chen; Haopeng Sun
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

5.  Selective Inhibitors of a Human Prolyl Hydroxylase (OGFOD1) Involved in Ribosomal Decoding.

Authors:  Cyrille C Thinnes; Christopher T Lohans; Martine I Abboud; Tzu-Lan Yeh; Anthony Tumber; Radosław P Nowak; Martin Attwood; Matthew E Cockman; Udo Oppermann; Christoph Loenarz; Christopher J Schofield
Journal:  Chemistry       Date:  2019-01-08       Impact factor: 5.236

6.  Synthesis and Photophysical Properties of a Series of Dimeric Indium Quinolinates.

Authors:  Sang Woo Kwak; Ju Hyun Hong; Sanghun Lee; Min Kim; Yongseog Chung; Kang Mun Lee; Youngjo Kim; Myung Hwan Park
Journal:  Molecules       Date:  2020-12-23       Impact factor: 4.411

7.  Characterization of Aminobenzylphenols as Protein Disulfide Isomerase Inhibitors in Glioblastoma Cell Lines.

Authors:  Andrea Shergalis; Ding Xue; Fatma Z Gharbia; Hannah Driks; Binita Shrestha; Amina Tanweer; Kirin Cromer; Mats Ljungman; Nouri Neamati
Journal:  J Med Chem       Date:  2020-09-11       Impact factor: 7.446

8.  KDM4A regulates HIF-1 levels through H3K9me3.

Authors:  Grzegorz Dobrynin; Tom E McAllister; Katarzyna B Leszczynska; Shaliny Ramachandran; Adam J Krieg; Akane Kawamura; Ester M Hammond
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

9.  Synthesis and Cytoprotective Characterization of 8-Hydroxyquinoline Betti Products.

Authors:  Iván Kanizsai; Ramóna Madácsi; László Hackler; Márió Gyuris; Gábor J Szebeni; Orsolya Huzián; László G Puskás
Journal:  Molecules       Date:  2018-08-02       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.